Amundi
CL icon

Amundi’s Colgate-Palmolive CL Stock Holding History

Amundi’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570M Buy
6,218,257
+1,033,918
+20% +$90.5M 0.14% 131
2026
Q1 		$442M Sell
5,184,339
-1,072,017
-17% -$95.5M 0.12% 154
2025
Q4 		$494M Sell
6,256,356
-38,089
-0.6% -$2.99M 0.13% 156
2025
Q3 		$488M Buy
6,294,445
+1,850,412
+42% +$158M 0.16% 117
2025
Q2 		$411M Sell
4,444,033
-676,761
-13% -$61.8M 0.14% 141
2025
Q1 		$492M Sell
5,120,794
-4,079,350
-44% -$365M 0.18% 118
2024
Q4 		$806M Buy
9,200,144
+1,040,604
+13% +$99.3M 0.28% 77
2024
Q3 		$822M Sell
8,159,540
-1,210,577
-13% -$123M 0.3% 73
2024
Q2 		$899M Sell
9,370,117
-4,406,303
-32% -$406M 0.34% 64
2024
Q1 		$1.2B Buy
13,776,420
+1,428,058
+12% +$121M 0.51% 30
2023
Q4 		$997M Buy
12,348,362
+1,750,368
+17% +$132M 0.45% 37
2023
Q3 		$752M Buy
10,597,994
+1,566,591
+17% +$117M 0.37% 52
2023
Q2 		$697M Sell
9,031,403
-113,998
-1% -$8.82M 0.35% 56
2023
Q1 		$689M Buy
9,145,401
+1,600,732
+21% +$119M 0.37% 53
2022
Q4 		$582M Buy
7,544,669
+1,732,947
+30% +$130M 0.32% 81
2022
Q3 		$413M Buy
5,811,722
+3,014,618
+108% +$236M 0.25% 103
2022
Q2 		$219M Sell
2,797,104
-379,226
-12% -$29.7M 0.18% 146
2022
Q1 		$255M Buy
3,176,330
+445,034
+16% +$35.3M 0.17% 144
2021
Q4 		$225M Buy
2,731,296
+94,230
+4% +$7.36M 0.14% 171
2021
Q3 		$199M Buy
2,637,066
+36,613
+1% +$2.91M 0.14% 176
2021
Q2 		$212M Buy
+2,600,453
New +$213M 0.15% 165

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Amundi's CL Position: Q2 2026 in Review

Amundi increased its Colgate-Palmolive (CL) stake by 20% in Q2 2026, buying an estimated $90.5M and bringing the position to 6,218,257 shares worth $570M. The position accounts for 0.14% of the portfolio, ranked #131.

Amundi first reported a position in CL in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.2B in Q1 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Amundi held 6,218,257 shares of Colgate-Palmolive worth $570M as of Q2 2026.
  • Amundi bought 1,033,918 Colgate-Palmolive shares in Q2 2026, an estimated $90.5M.
  • Colgate-Palmolive made up 0.14% of Amundi's portfolio in Q2 2026, its #131 holding.
  • Amundi first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Colgate-Palmolive position peaked at $1.2B in Q1 2024.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.